share_log

Trevi Therapeutics Has Priced An Underwritten Offering Of 12.5M Shares At $4.00 Per Share, For Total Proceeds Of $50M

Benzinga ·  Dec 16 20:38
Trevi Therapeutics Has Priced An Underwritten Offering Of 12.5M Shares At $4.00 Per Share, For Total Proceeds Of $50M
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment